Literature DB >> 27473509

Ocular surface microbiome in meibomian gland dysfunction.

Grant A Watters1,2, Philip R Turnbull2, Simon Swift3, Alex Petty1,2, Jennifer P Craig1.   

Abstract

BACKGROUND: To investigate the ocular microbiome in meibomian gland dysfunction in Auckland, New Zealand.
DESIGN: Prospective, cross-sectional, observational, university-based study. PARTICIPANTS: Participants resident in New Zealand for ≥2 years (n = 157) were classified as normal (n = 66), mild (n = 41) or moderate-to-severe meibomian gland dysfunction (n = 50). Contact lens wear and anterior blepharitis status were recorded, as well as symptoms and clinical features.
METHODS: Bacteria collected from lid margin swabs, before and after gland expression, were isolated and identified by conventional microbiological culture techniques. Aerobic isolates were identified in all 157 participants, and both aerobic and anaerobic bacteria isolated in a subset of 87 subjects. MAIN OUTCOME MEASURES: Bacterial incidence according to meibomian gland dysfunction status
RESULTS: Symptoms, bulbar hyperaemia, conjunctival staining, lipid layer grade and tear film stability, but not corneal staining, showed moderate association with meibomian gland dysfunction severity. Participants with and without meibomian gland dysfunction showed a similar microbiome, unaffected by gland expression. Anterior blepharitis, a common co-morbidity, was not an independent predictor of the microbiome. Sterile cultures were more common in contact lens wearers than non-wearers. The incidence of Staphylococcus aureus was higher than anticipated across all severity groups, and that of coagulase-negative Staphylococcus, Corynebacterium and streptococci was lower.
CONCLUSIONS: Modest differences in relative proportions of bacteria compared with other studies support climatic variations in the ocular surface microbiome. Similarity in microbiome profile, irrespective of meibomian gland dysfunction severity, anterior blepharitis presence or contact lens wear, suggests potential for commonality in treatment.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  bacteria; blepharitis; dry eye; meibomian gland dysfunction; microbiome

Mesh:

Year:  2016        PMID: 27473509     DOI: 10.1111/ceo.12810

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  22 in total

1.  Assessing the ocular surface microbiome in severe ocular surface diseases.

Authors:  Michael J Zilliox; William S Gange; Gina Kuffel; Carine R Mores; Cara Joyce; Paul de Bustros; Charles S Bouchard
Journal:  Ocul Surf       Date:  2020-07-24       Impact factor: 5.033

Review 2.  [Blepharitis component of dry eye syndrome].

Authors:  C Auw-Hädrich; T Reinhard
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

Review 3.  The microbiome and ophthalmic disease.

Authors:  Adam D Baim; Asadolah Movahedan; Asim V Farooq; Dimitra Skondra
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-21

4.  Meibomian gland dysfunction in geriatric population: tehran geriatric eye study.

Authors:  Hassan Hashemi; Amir Asharlous; Mohamadreza Aghamirsalim; Abbasali Yekta; Rama Pourmatin; Masoome Sajjadi; Mojgan Pakbin; Mohammadreza Asadollahi; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2021-03-24       Impact factor: 2.031

Review 5.  The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas.

Authors:  Fu-Shin X Yu; Patrick S Y Lee; Lingling Yang; Nan Gao; Yangyang Zhang; Alexander V Ljubimov; Ellen Yang; Qingjun Zhou; Lixin Xie
Journal:  Prog Retin Eye Res       Date:  2022-01-04       Impact factor: 19.704

6.  Staphylococcus aureus alpha-hemolysin impairs corneal epithelial wound healing and promotes intracellular bacterial invasion.

Authors:  Ilham Putra; Behnam Rabiee; Khandaker N Anwar; Sanaz Gidfar; Xiang Shen; Mehrdad Babalooee; Mahmood Ghassemi; Neda Afsharkhamseh; Saaquib Bakhsh; Dominique Missiakas; Ali Nezamabadi; Behrad Milani; Medi Eslani; Ali R Djalilian
Journal:  Exp Eye Res       Date:  2019-02-27       Impact factor: 3.467

Review 7.  The ocular surface immune system through the eyes of aging.

Authors:  Jeremias G Galletti; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2021-02-20       Impact factor: 5.033

8.  Preclinical development of MGO Manuka Honey microemulsion for blepharitis management.

Authors:  Jennifer P Craig; Ilva D Rupenthal; Ali Seyfoddin; Isabella M Y Cheung; Benedict Uy; Michael T M Wang; Grant A Watters; Simon Swift
Journal:  BMJ Open Ophthalmol       Date:  2017-08-07

9.  Randomised masked trial of the clinical safety and tolerability of MGO Manuka Honey eye cream for the management of blepharitis.

Authors:  Jennifer P Craig; Michael T M Wang; Kalaivarny Ganesalingam; Ilva D Rupenthal; Simon Swift; Chee Seang Loh; Leah Te Weehi; Isabella M Y Cheung; Grant A Watters
Journal:  BMJ Open Ophthalmol       Date:  2017-08-04

Review 10.  Influence of gut microbiota on eye diseases: an overview.

Authors:  Pasquale Napolitano; Mariaelena Filippelli; Sergio Davinelli; Silvia Bartollino; Roberto dell'Omo; Ciro Costagliola
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.